SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

With no major difference for the quarter endedDecember 2025 , the total revenue stood at Rs. 1892.20  millions.The Company has registered profit of Rs. 872.80  millions for the quarter ended December 2025, a growth of 16.83%  over Rs. 747.10 millions millions achieved in the corresponding quarter of last year.Operating Profit saw a handsome growth to 1234.50 millions from 1062.20 millions in the quarter ended December 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 1892.20 1852.30 2.15 5469.70 5788.00 -5.50 7524.10 6250.90 20.37
Other Income 317.30 288.30 10.06 1229.80 933.40 31.75 1345.90 1058.40 27.16
PBIDT 1234.50 1062.20 16.22 3771.60 3502.70 7.68 4665.60 3929.20 18.74
Interest 0.70 0.40 75.00 1.60 0.80 100.00 1.20 1.00 20.00
PBDT 1233.80 1061.80 16.20 3770.00 3501.90 7.66 4664.40 3928.20 18.74
Depreciation 63.70 60.10 5.99 185.30 186.80 -0.80 247.70 270.80 -8.53
PBT 1170.10 1001.70 16.81 3584.70 3315.10 8.13 4416.70 3657.40 20.76
TAX 297.30 254.60 16.77 827.10 785.20 5.34 1021.80 820.30 24.56
Deferred Tax 3.80 -0.90 -522.22 -3.20 -7.50 -57.33 -7.20 -40.90 -82.40
PAT 872.80 747.10 16.83 2757.60 2529.90 9.00 3394.90 2837.10 19.66
Equity 152.00 152.00 0.00 152.00 152.00 0.00 152.00 151.90 0.07
PBIDTM(%) 65.24 57.34 13.77 68.95 60.52 13.94 62.01 62.86 -1.35

Caplin Point Lab Share Price

1748.25 -6.00 (-0.34%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×